前列腺癌化疗安全共识

2018-02-20 中国医促会泌尿健康促进分会 现代泌尿外科杂志.2018.23(2):85-92.

新辅助化疗和根治术后的辅助化疗可能进一步扩大化疗在前列腺癌治疗中的应用范围,但是,尚缺乏有效的前瞻性临床证据。 虽然多西他赛单药化疗简单易行,但是,绝大多数前列腺癌患者为高龄人群,且多合并各种基础疾病。因此,安全有效地使用化疗对保障和提高化疗疗效和生活质量具有重要意义。 本共识将从条件保障、人员培训、并发症防治和患者管理等方面,多角度推荐前列腺癌患者化疗的安全共识,希望能为化疗在中

中文标题:

前列腺癌化疗安全共识

发布日期:

2018-02-20

简要介绍:

新辅助化疗和根治术后的辅助化疗可能进一步扩大化疗在前列腺癌治疗中的应用范围,但是,尚缺乏有效的前瞻性临床证据。

虽然多西他赛单药化疗简单易行,但是,绝大多数前列腺癌患者为高龄人群,且多合并各种基础疾病。因此,安全有效地使用化疗对保障和提高化疗疗效和生活质量具有重要意义。

本共识将从条件保障、人员培训、并发症防治和患者管理等方面,多角度推荐前列腺癌患者化疗的安全共识,希望能为化疗在中国前列腺癌患者中的临床应用保驾护航。

 

拓展指南:前列腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=前列腺癌化疗安全共识)] GetToolGuiderByIdResponse(projectId=1, id=0fa341c0015e557a, title=前列腺癌化疗安全共识, enTitle=, guiderFrom=现代泌尿外科杂志.2018.23(2):85-92., authorId=null, author=, summary=新辅助化疗和根治术后的辅助化疗可能进一步扩大化疗在前列腺癌治疗中的应用范围,但是,尚缺乏有效的前瞻性临床证据。 虽然多西他赛单药化疗简单易行,但是,绝大多数前列腺癌患者为高龄人群,且多合并各种基础疾病。因此,安全有效地使用化疗对保障和提高化疗疗效和生活质量具有重要意义。 本共识将从条件保障、人员培训、并发症防治和患者管理等方面,多角度推荐前列腺癌患者化疗的安全共识,希望能为化疗在中, cover=, journalId=null, articlesId=null, associationId=1623, associationName=中国医促会泌尿健康促进分会, associationIntro=, copyright=0, guiderPublishedTime=Tue Feb 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>新辅助化疗和根治术后的辅助化疗可能进一步扩大化疗在前列腺癌治疗中的应用范围,但是,尚缺乏有效的前瞻性临床证据。 <BR><BR>虽然多西他赛单药化疗简单易行,但是,绝大多数前列腺癌患者为高龄人群,且多合并各种基础疾病。因此,安全有效地使用化疗对保障和提高化疗疗效和生活质量具有重要意义。 <BR><BR>本共识将从条件保障、人员培训、并发症防治和患者管理等方面,多角度推荐前列腺癌患者化疗的安全共识,希望能为化疗在中国前列腺癌患者中的临床应用保驾护航。</P> <P> </P>拓展指南:<STRONG>与<FONT color=red>前列腺癌</FONT>相关指南:</STRONG><BR> <UL> <LI><A title=NCCN临床实践指南:前列腺癌早期检测(2018.V1) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=9a1df1c00156801b">NCCN临床实践指南:前列腺癌早期检测(2018.V1)</A> <LI><A title=前列腺特异性膜抗原靶向分子影像检查在前列腺癌患者中应用的中国专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=fbadf1c00155a53e">前列腺特异性膜抗原靶向分子影像检查在前列腺癌患者中应用的中国专家共识</A> <LI><A title="2017 EANM指南:转移性去势难治性前列腺癌应用镭-233放射治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=342ff1c0015353aa">2017 EANM指南:转移性去势难治性前列腺癌应用镭-233放射治疗</A> <LI><A title="2017 HKUA/HKSUO共识声明:转移性前列腺癌的管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=683591c001529a48">2017 HKUA/HKSUO共识声明:转移性前列腺癌的管理</A> <LI><A title=中国前列腺癌外科治疗专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=c72151c001512170">中国前列腺癌外科治疗专家共识</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C">有关前列腺癌更多指南</A></LI></UL>, tagList=[TagDto(tagId=781, tagName=前列腺癌), TagDto(tagId=72647, tagName=化疗安全)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5245, appHits=282, showAppHits=7, pcHits=4009, showPcHits=1396, likes=110, shares=9, comments=4, approvalStatus=1, publishedTime=Tue Apr 03 22:06:38 CST 2018, publishedTimeString=2018-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 03 22:06:38 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:33:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=前列腺癌化疗安全共识)])
前列腺癌化疗安全共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=303631, encodeId=3807303631f9, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Apr 07 19:08:12 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302473, encodeId=cd483024e339, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:04 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302466, encodeId=9768302466eb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Tue Apr 03 22:42:48 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302458, encodeId=9a8130245802, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:18 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-07 131****1460

    学习了受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=303631, encodeId=3807303631f9, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Apr 07 19:08:12 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302473, encodeId=cd483024e339, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:04 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302466, encodeId=9768302466eb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Tue Apr 03 22:42:48 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302458, encodeId=9a8130245802, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:18 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-03 1e1b8538m79(暂无匿称)

    不错的文章值得拥有

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=303631, encodeId=3807303631f9, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Apr 07 19:08:12 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302473, encodeId=cd483024e339, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:04 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302466, encodeId=9768302466eb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Tue Apr 03 22:42:48 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302458, encodeId=9a8130245802, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:18 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-03 戒馋,懒,贪

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=303631, encodeId=3807303631f9, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Apr 07 19:08:12 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302473, encodeId=cd483024e339, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:04 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302466, encodeId=9768302466eb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Tue Apr 03 22:42:48 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302458, encodeId=9a8130245802, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:18 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-03 wqkm

    ^_^^_^^_^

    0